KLDO
Kaleido Biosciences, Inc.
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Neutral
-18/100
Last price
0.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
1.05K
Market cap
$4.26K
P/E (TTM)
—
52W range
0.00 – 0.20
Trailing performance
Returnvs SPY
1W
0.00%
-1.9%
1M
0.00%
-1.2%
3M
0.00%
-4.5%
6M
0.00%
-18.2%
YTD
0.00%
-14.2%
1Y
0.00%
-16.4%
3Y
0.00%
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on KLDO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap$4.26K
Enterprise value$-16.78M
Revenue (TTM)$1.10M
Gross profit$-66.70M
EBITDA$-85.16M
Net income$-90.29M
EPS (TTM)$-2.16
Free cash flow$-46.02M
Total cash$38.47M
Total debt$21.69M
Book value / share$0.25
Shares outstanding42.62M
Float42.45M
Short % of float8.52%
Dividend yield0.00%
Beta (5Y)36.84
Valuation & profitability ratios
Trailing P/E—
Forward P/E-0.00
PEG ratio—
Price / sales—
Price / book0.00
EV / revenue-15.20
EV / EBITDA0.20
Gross margin0.00%
Operating margin-3974.39%
Profit margin0.00%
Return on equity-580.57%
Return on assets-99.93%
Debt / equity204.53
Current ratio1.43
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2021 | YoY |
|---|---|---|
| Total revenue | $1.10M | |
| Operating revenue | $1.10M | |
| Research & development | $67.80M | |
| Selling, general & admin | $20.97M | |
| Total operating expense | $88.77M | |
| Operating income | -$87.67M | |
| Net interest income | -$2.77M | |
| Pre-tax income | -$90.29M | |
| Net income | -$90.29M | |
| Net income to common | -$90.29M | |
| EBIT | -$87.45M | |
| EBITDA | -$85.09M |
| Line item | 2021 | YoY |
|---|---|---|
| Cash & equivalents | $38.47M | |
| Cash & short-term investments | $38.47M | |
| Total current assets | $42.31M | |
| Property, plant & equipment | $5.67M | |
| Total assets | $50.14M | |
| Total current liabilities | $29.68M | |
| Current debt | $16.14M | |
| Long-term debt | $5.55M | |
| Total debt | $21.69M | |
| Total liabilities | $39.53M | |
| Retained earnings | -$364.47M | |
| Shareholder equity | $10.61M | |
| Working capital | $12.63M | |
| Net tangible assets | $10.61M | |
| Shares issued | 42.60M |
| Line item | 2021 | YoY |
|---|---|---|
| Net income | -$90.29M | |
| Depreciation & amortisation | $2.36M | |
| Stock-based compensation | $10.34M | |
| Change in working capital | -$263.00K | |
| Operating cash flow | -$77.09M | |
| Capital expenditure | -$1.13M | |
| Investing cash flow | -$691.00K | |
| Financing cash flow | $70.04M | |
| Free cash flow | -$78.22M | |
| End cash position | $40.63M |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Dec 2021 | -0.58 | -0.48 | +17.2% |
| Sep 2021 | -0.54 | -0.54 | -0.8% |
| Jun 2021 | -0.58 | -0.56 | +3.4% |
| Mar 2021 | -0.60 | -0.58 | +4.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions0.06%
Institutions holding5
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.00
+0.00% from price
SMA 20
0.00
0.00% from price
SMA 50
0.00
+3.73% from price
SMA 100
0.00
-2.15% from price
SMA 200
0.00
-3.47% from price
EMA 12
0.00
+0.01% from price
EMA 26
0.00
+0.32% from price
EMA 50
0.00
+0.25% from price
RSI (14)
52.7
Neutral
MACD (12,26,9)
0.00
Hist -0.00
ATR (14)
0.00
707.14% of price
Realised vol 30D
0.0%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.00
Trend bias
Below 200
-3.47%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
23.29
More volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
0.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-99.8%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
707.14% of price
Beta (reported)
36.84
5Y monthly, from filing
Short interest
Shares short
1.40M
Prior 2.33M
Change vs prior
-39.8%
Shorts covering
% of float
8.52%
Normal
% of shares out
3.29%
Against total outstanding
Days to cover
0.1
Liquid
Float
42.45M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 4, 22 | Chardan Capital | DOWNGRADE | Buy | Neutral |
| Jan 31, 22 | Chardan Capital | MAINTAINED | — | Buy |
| Nov 12, 21 | Chardan Capital | MAINTAINED | — | Buy |
| Nov 3, 21 | JMP Securities | MAINTAINED | — | Market Outperform |
| Oct 19, 21 | Morgan Stanley | DOWNGRADE | Equal-Weight | Underweight |
| Mar 8, 21 | Morgan Stanley | MAINTAINED | — | Equal-Weight |
| Feb 9, 21 | Piper Sandler | INITIATED | — | Overweight |
| Jan 19, 21 | Morgan Stanley | MAINTAINED | — | Equal-Weight |
| Dec 23, 20 | JMP Securities | INITIATED | — | Outperform |
| Aug 10, 20 | Morgan Stanley | MAINTAINED | — | Equal-Weight |
| Jul 15, 20 | Morgan Stanley | MAINTAINED | — | Equal-Weight |
| May 21, 20 | Morgan Stanley | DOWNGRADE | Overweight | Equal-Weight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Tender Offer/Acquisition Reports
SC 13G/A · 2022-05-10
Notice of termination of registration of a class of securities under Section 12(b)
15-12B · 2022-05-06
Offering Registrations
S-8 POS · 2022-04-25
Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
25 · 2022-04-18
Corporate Changes & Voting Matters
8-K · 2022-04-08
Periodic Financial Reports
10-K · 2022-04-01
Corporate Changes & Voting Matters
8-K · 2022-03-17
Corporate Changes & Voting Matters
8-K · 2022-03-09
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.